Bonus BioGroup Ltd.
BBIXF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $3,366 | $4,097 |
| Gross Profit | $0 | $0 | -$3,366 | -$4,097 |
| % Margin | – | – | – | – |
| R&D Expenses | $17,605 | $18,613 | $21,312 | $20,792 |
| G&A Expenses | $10,231 | $11,177 | $5,463 | $31,340 |
| SG&A Expenses | $10,231 | $11,177 | $5,463 | $31,340 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $31 | $6,906 | $8,506 |
| Operating Expenses | $27,836 | $29,821 | $33,681 | $60,638 |
| Operating Income | -$27,836 | -$29,790 | -$37,047 | -$64,735 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $10 | $1,261 | -$1,656 | -$25,341 |
| Pre-Tax Income | -$27,826 | -$28,529 | -$38,703 | -$90,076 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$27,826 | -$28,529 | -$38,703 | -$90,076 |
| % Margin | – | – | – | – |
| EPS | -0.024 | -0.024 | -0.033 | -0.078 |
| % Growth | 2.5% | 26.3% | 57.6% | – |
| EPS Diluted | -0.024 | -0.024 | -0.033 | -0.078 |
| Weighted Avg Shares Out | 1,167,932 | 1,167,928 | 1,167,925 | 1,153,748 |
| Weighted Avg Shares Out Dil | 1,167,925 | 1,167,925 | 1,167,925 | 1,153,740 |
| Supplemental Information | – | – | – | – |
| Interest Income | $49 | $1 | $7,282 | $164 |
| Interest Expense | $0 | $0 | $891 | $569 |
| Depreciation & Amortization | $1,633 | $1,652 | $2,663 | $1,476 |
| EBITDA | -$26,203 | -$28,138 | -$35,149 | -$88,031 |
| % Margin | – | – | – | – |